DERM

Journey Medical Corp

NasdaqAdd to watchlist

Healthcare · Drug Manufacturers—Specialty & Generic

$7.31

−$0.05−0.68%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

Aug 24, 2026$7.31

−$0.60−7.59%over 1M

Session

Day range8% of range

$7.29$7.61

Fundamentals

Visualize fundamentals and more

Market cap: 200.98M
P/E ratio: -

Revenue grew +10.20% in FY2025, in line with its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 21
dropped: 18
re-drafted: 39

Out of 288 passages in this year’s Item 1A.

New this year

Also, a substantial portion of our sales derive from products that may become subject to third-party generic competition because their period of exclusivity has ended or they are without patent protection, subjecting them to the potential introduction of new …

38 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Litigation
Reimbursement
Patent expiry
Product recalls
Tariffs
Cybersecurity
Export controls

And 13 more.

FDA approval
Further, we are only permitted to promote our products for those indications specifically approved by the FDA and there are restrictions around making communications regarding uses not approved and described in the product’s labeling. If our promotional …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

13 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

Journey Medical Corp investor relations

What DERM has filed with the SEC. This is not Journey Medical Corp’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Journey Medical Corp

Also filed under Drug Manufacturers, ranked by how closely they sit beside DERM.

LLYELI LILLY & Cocompare with DERM
JNJJohnson & Johnsoncompare with DERM
AMGNAmgen Inc.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Litigation
Reimbursement
Patent expiry
Product recalls
Tariffs
Cybersecurity
Export controls

And 13 more.

FDA approval
Further, we are only permitted to promote our products for those indications specifically approved by the FDA and there are restrictions around making communications regarding uses not approved and described in the product’s labeling. If our promotional …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

MRKMerck & Co., Inc.compare with DERM

BMYBristol Myers Squibb Co.compare with DERM

Ask about Journey Medical Corp

The assistant answers from what DERM has actually filed: 6 annual reports filed with the SEC, 11 Form 4 filings from the last year and 1 fund that holds it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from DERM's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of Journey Medical Corp each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Journey Medical Corp

Be told the moment a DERM insider trades
Put Journey Medical Corp on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Journey Medical Corp's income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Journey Medical Corp's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 21
dropped: 18
re-drafted: 39

Out of 288 passages in this year’s Item 1A.

New this year

Also, a substantial portion of our sales derive from products that may become subject to third-party generic competition because their period of exclusivity has ended or they are without patent protection, subjecting them to the potential introduction of new …

38 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add